A Nanocapsule System Combats Aging by Inhibiting Age-Related Angiogenesis Deficiency and Glucolipid Metabolism Disorders

• Published in: ACS nano 2024-08, Vol.18 (32), p.21061-21076
• Main Authors: Li, Bo, Zhang, Qiang, Cheng, Jiahui, Feng, Yanfei, Jiang, Lixian, Zhao, Xinxin, Lv, Yang, Yang, Kun, Shi, Jiaran, Wei, Wei, Guo, Peng, Wang, Jun, Cao, Mengqiu, Ding, Weina, Wang, Ji, Su, Diansan, Zhou, Yan, Gao, Rifeng
• Format: Article
• Language: English
• Subjects: Aging - metabolism; Angiogenesis; Animals; Cellular Senescence - drug effects; Glycolipids - chemistry; Glycolipids - metabolism; Human Umbilical Vein Endothelial Cells - metabolism; Humans; Mice; Mice, Inbred C57BL; Nanocapsules - chemistry; Neovascularization, Pathologic - drug therapy; Neovascularization, Pathologic - metabolism
• ISSN: 1936-0851; 1936-086X; 1936-086X
• DOI: 10.1021/acsnano.4c02269

Insufficient angiogenic stimulation and dysregulated glycolipid metabolism in senescent vascular endothelial cells (VECs) constitute crucial features of vascular aging. Concomitantly, the generation of excess senescence-associated secretory phenotype (SASP) and active immune-inflammatory responses propagates within injured vessels, tissues, and organs. Until now, targeted therapies that efficiently rectify phenotypic abnormalities in senescent VECs have still been lacking. Here, we constructed a Pd/hCeO2–BMS309403@platelet membrane (PCBP) nanoheterostructured capsule system loaded with fatty acid-binding protein 4 (FABP4) inhibitors and modified with platelet membranes and investigated its therapeutic role in aged mice. PCBP showed significant maintenance in aged organs and demonstrated excellent biocompatibility. Through cyclic tail vein administration, PCBP extended the lifespan and steadily ameliorated abnormal phenotypes in aged mice, including SASP production, immune and inflammatory status, and age-related metabolic disorders. In senescent ECs, PCBP mediated the activation of vascular endothelial growth factor (VEGF) signaling and glycolysis and inhibition of FABP4 by inducing the synthesis of hypoxia-inducible factor-1α, thereby reawakening neovascularization and restoring glycolipid metabolic homeostasis. In conclusion, the PCBP nanocapsule system provides a promising avenue for interventions against aging-induced dysfunction.